Related Experiment Video
Updated: Jul 15, 2026

07:59
A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes
Published on: March 25, 2014
A hybrid approach for predicting promiscuous MHC class I restricted T cell epitopes
1Institute of Microbial Technology, Sector 39A, Chandigarh 160 036, India.
Journal of Biosciences
|April 12, 2007
Summary
A new hybrid method combining quantitative matrix and artificial neural network approaches accurately predicts T cell epitopes for 67 MHC class I alleles. This tool identifies promiscuous MHC binders with proteasomal cleavage sites, improving epitope prediction accuracy.
Area of Science:
- Immunoinformatics
- Computational Biology
- T Cell Epitope Prediction
Background:
- Accurate prediction of T cell epitopes is crucial for vaccine design and immunotherapy.
- Existing methods for predicting MHC class I binders have limitations in accuracy and allele coverage.
Purpose of the Study:
- To develop a highly accurate and broadly applicable method for predicting MHC class I restricted T cell epitopes.
- To enhance the prediction of promiscuous MHC binders with desirable characteristics for T cell activation.
Main Methods:
- Developed a quantitative matrix (QM)-based method for 47 MHC class I alleles.
- Developed an artificial neural network (ANN)-based method for 30 alleles with sufficient data.
- Combined QM and ANN methods into a hybrid approach, achieving improved prediction accuracy.
Main Results:
- The hybrid method achieved an average accuracy of 92.8% for 30 MHC alleles.
- The method enables prediction for a total of 67 MHC class I alleles, including 20 additional alleles via QM.
- The approach successfully identifies T cell epitopes with proteasomal cleavage sites, a key feature for antigen processing.
Conclusions:
- The developed hybrid method offers superior accuracy and broader allele coverage compared to existing T cell epitope prediction tools.
- This user-friendly tool aids in identifying promiscuous MHC binders, facilitating the design of effective immunotherapies and vaccines.
- The method is accessible online, promoting its use in immunological research and drug discovery.
Related Concept Videos
Antigens Involved in Adaptive Immunity
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Cross-reactivity
Overview
Hybridoma Technology
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Antigen Processing Pathways
MHC molecules are key players in the immune response, enabling T cells to recognize and respond to specific antigens. They are present on the surface of all nucleated cells in the body and are instrumental in presenting antigens to T cells and activating them. T cells recognize the MHC-antigen complex and initiate an immune response. MHC class I and MHC class II are two main types of MHC molecules, each associated with a distinct antigen processing pathway.
MHC Class I: Presenting Endogenous...
MHC Class I: Presenting Endogenous...
T Cell Activation and Clonal Selection
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
Diversity of Antigen Receptors
Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...

